UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development

Cancer letters, 2021-06, Vol.507, p.26-38

2021

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells

Journal of Virology, 2004-05, Vol.78 (10), p.5223-5232

2004

Volltextzugriff (PDF)

Measles Virus Vaccine―Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells

Clinical cancer research, 2013-03, Vol.19 (5), p.1147-1158

2013

Volltextzugriff (PDF)

Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy

Respiratory research, 2024-04, Vol.25 (1), p.156-156, Article 156

2024

Volltextzugriff (PDF)

A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming

The Journal of immunology (1950), 2014-02, Vol.192 (4), p.1962-1971

2014

Volltextzugriff (PDF)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy

Frontiers in oncology, 2021-06, Vol.11, p.695770-695770

2021

Volltextzugriff (PDF)

The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles

Frontiers in immunology, 2022-07, Vol.13, p.925241-925241

2022

Volltextzugriff (PDF)

Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

Blood, 2003-05, Vol.101 (9), p.3520-3526

2003

Volltextzugriff (PDF)

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000182

2020

Volltextzugriff (PDF)

A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death

Methods in molecular biology (Clifton, N.J.), 2020-01, Vol.2058, p.127

2020

Volltextzugriff (PDF)

MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge

BioMed research international, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response

Oncotarget, 2015-12, Vol.6 (42), p.44892-44904

2015

Volltextzugriff (PDF)

Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment

Oncoimmunology, 2024-12, Vol.13 (1), p.2377830

2024

Volltextzugriff (PDF)

Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways

Stem cell research & therapy, 2022-01, Vol.13 (1), p.7-7, Article 7

2022

Volltextzugriff (PDF)

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells

Oncoimmunology, 2018-03, Vol.7 (3), p.e1407897-e1407897

2018

Volltextzugriff (PDF)

Viral cancer therapies: are they ready for combination with other immunotherapies?

Future oncology (London, England), 2017-08, Vol.13 (18), p.1569-1571

2017

Volltextzugriff (PDF)

Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi

European journal of immunology, 2012-03, Vol.42 (3), p.783-789

2012

Volltextzugriff (PDF)

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma

JTO clinical and research reports, 2022-12, Vol.3 (12), p.100430-100430, Article 100430

2022

Volltextzugriff (PDF)

High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma

Molecular therapy. Oncolytics, 2020-09, Vol.18, p.573-578

2020

Volltextzugriff (PDF)

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1750-1758

1998

Volltextzugriff (PDF)

Oncolytic immunotherapy: The new clinical outbreak

Oncoimmunology, 2016-01, Vol.5 (1), p.e1066961-e1066961

2016

Volltextzugriff (PDF)

TP53 mutations correlate with the non‐coding RNA content of small extracellular vesicles in melanoma

Journal of extracellular biology, 2023-08, Vol.2 (8), p.e105-n/a

2023

Volltextzugriff (PDF)

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells

Oncotarget, 2014-06, Vol.5 (12), p.4504-4515

2014

Volltextzugriff (PDF)

MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma

Cancer immunology research, 2020-02, Vol.8 (2), p.255-267

2020

Volltextzugriff (PDF)

Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth

Vaccine, 2011-07, Vol.29 (33), p.5534-5543

2011

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(94)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Humans
(55)
Life Sciences
(51)
Cancer
(43)
Immunology
(39)
Oncology
(32)
Dendritic Cells - Immunology
(19)
Dendritic Cells
(18)
Immunotherapy
(18)
Mesothelioma
(16)
Melanoma - Immunology
(15)
T-Lymphocytes, Cytotoxic - Immunology
(15)
Antigens, Neoplasm - Immunology
(14)
Biological And Medical Sciences
(14)
Cd8-Positive T-Lymphocytes - Immunology
(14)
Cell Line, Tumor
(14)
Animals
(12)
Medical Sciences
(11)
Tumors
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development

Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells

Measles Virus Vaccine―Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells

Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy

A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy

The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles

Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death

MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response

Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment

Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells

Viral cancer therapies: are they ready for combination with other immunotherapies?

Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma

High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

Oncolytic immunotherapy: The new clinical outbreak

TP53 mutations correlate with the non‐coding RNA content of small extracellular vesicles in melanoma

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells

MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma

Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth

Suchergebnisse filtern